Methods of treating pancreatic cancer
US10328031B2 · kind B2 · utility
11Cited by
59References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 21, 2017 |
| Grant date | Jun 25, 2019 |
| Priority date | — |
| Expiry date | Dec 3, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods for the treatment of metastatic pancreatic cancer comprising administration of a composition comprising nanoparticles comprising a taxane (such as paclitaxel) and a carrier protein in combination with gemcitabine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.